Alterity Therapeutics Is A Clinical Stagebiotechnology Company Based In Melbourneaustraliawith Operations In San Franciscocaliforniathecompany Is Dedicated To Developing Innovativetreatments For Neurodegenerativediseases And Is Listed On Theaustralian Securities Exchangeasx Thecompany Specializes In Creating First In Class Therapiesparticularly Small Molecules That Inhibit Theaggregation Of Pathological Proteins Involved In Neurodegenerationtheir Lead Drug Candidateath4 4Is Currently Undergoing Two Phase2 Clinical Trials For Multiplesystem Atrophymsa Ath4 4 Has Demonstrated Potential In Preclinical Studies By Reducing Isynuclein Pathology And Preserving Nervecellsalterity Therapeutics Also Has A Drug Discovery Platform That Focuses On Generating Patentablecompounds To Address Various Neurodegenerativeconditionsled By Ceo David Stamleralterity Therapeutics Actively Raises Capital To Support Its Research And Development Initiativesreflecting Its Commitment To Advancing Treatments For Thoseaffected By Neurodegenerativediseases
